WALTHAM, MA – Vicarious Surgical Inc. (NYSE:RBOT) reported that its Chief Technology Officer, Sammy Khalifa, sold a total of 19,601 shares of company stock on May 20, 2024, primarily to satisfy tax withholding obligations related to the vesting of restricted stock units. The shares were sold at a weighted average price of $0.3881, with individual transactions ranging from $0.3799 to $0.3988 per share, amounting to a total of approximately $7,607.
The sale was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC) dated May 21, 2024. According to the filing, the transactions were made to cover tax obligations arising from the vesting of restricted stock units granted to Khalifa on May 19, 2022.
Following the sale, Khalifa still retains 1,196,376 shares of Vicarious Surgical Inc., indicating a continued investment in the company's future. The shares are held directly, showcasing the CTO's direct stake in the medical technology firm.
Vicarious Surgical, a company specializing in orthopedic, prosthetic, and surgical appliances and supplies, has seen its executives actively manage their stock holdings, with this recent transaction being a part of normal financial planning for equity-compensated employees.
Investors and shareholders are often keen on the trading activities of a company's insiders as it may provide insights into their perspective on the company's current valuation and future prospects. However, it is important to note that insider transactions can be influenced by various factors unrelated to a company's performance.
For further details or requests regarding the specific prices at which the shares were sold, the reporting person has committed to providing full information to the SEC staff, Vicarious Surgical Inc., or any security holder of the company upon request.
InvestingPro Insights
As Vicarious Surgical Inc. (NYSE:RBOT) navigates through the fiscal year, the company's financial health and market performance are key indicators for investors. According to InvestingPro data, RBOT currently holds a market capitalization of $52.56 million, which is a critical measure of the company's overall market value. However, the company's P/E Ratio stands at -0.92, reflecting that it is not generating net earnings at the moment, which is corroborated by its negative earnings per share (EPS) of -0.39 USD.
Despite recent insider transactions that may signal confidence in the company's future, RBOT's performance metrics show a complex picture. The company has experienced a significant 1-year price total return of -81.57%, indicating a substantial decline in share value over the past year. Yet, it's worth noting the strong short-term returns, with a 1-week price total return of 15.72% and a 1-month price total return of 32.43%.
InvestingPro Tips highlight that RBOT holds more cash than debt on its balance sheet, which can be a sign of financial stability. Additionally, two analysts have revised their earnings upwards for the upcoming period, hinting at potential optimism for the company's financial outlook. However, it is also important to consider that analysts do not anticipate the company will be profitable this year.
For investors looking to delve deeper into Vicarious Surgical Inc.'s financials and market performance, InvestingPro offers additional insights. There are 11 more InvestingPro Tips available at https://www.investing.com/pro/RBOT, which can provide a more comprehensive understanding of the company's position. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and explore a broader range of expert analyses and data to guide investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.